Quest Diagnostics Inc Business Combination, Consideration Transferred
Quest Diagnostics Inc (DGX) reported Business Combination, Consideration Transferred of $101.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation
us-gaap:BusinessCombinationConsiderationTransferred1 · last filed 2026-02-26
- Quest Diagnostics Inc business combination, consideration transferred for the quarter ending 2024-12-31 was $400.00M.
- Quest Diagnostics Inc business combination, consideration transferred for the quarter ending 2024-09-30 was $1.55B, a 77500.00% increase year-over-year.
- Quest Diagnostics Inc business combination, consideration transferred for the quarter ending 2024-06-30 was $100.00M.
- Quest Diagnostics Inc business combination, consideration transferred for the quarter ending 2024-03-31 was $148.00M.
- Quest Diagnostics Inc business combination, consideration transferred for fiscal 2025 was $101.00M, a 95.41% decline from fiscal 2024.
- Quest Diagnostics Inc business combination, consideration transferred for fiscal 2024 was $2.20B, a 214.74% increase from fiscal 2023.
- Quest Diagnostics Inc business combination, consideration transferred for fiscal 2023 was $699.00M, a 331.48% increase from fiscal 2022.
- Quest Diagnostics Inc business combination, consideration transferred for fiscal 2022 was $162.00M, a 53.18% decline from fiscal 2021.
| Period end | Business Combination, Consideration Transferred 3 month | Business Combination, Consideration Transferred 6 month | Business Combination, Consideration Transferred 9 month | Business Combination, Consideration Transferred 12 month | Business Combination, Consideration Transferred 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | $101.00M 10-K · filed 2026-02-26 | ||||
| 2024-12-31 | $400.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.95B derived: sum of 2 quarters · filed 2026-02-26 | $2.05B derived: sum of 3 quarters · filed 2026-02-26 | $2.20B 10-K · filed 2026-02-26 | |
| 2024-09-30 | $1.55B derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-23 | $1.65B derived: sum of 2 quarters · filed 2024-10-23 | $1.80B 10-Q · filed 2024-10-23 | $1.80B derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-06-30 | $100.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-24 | $248.00M 10-Q · filed 2024-07-24 | $248.00M derived: sum of 3 quarters · filed 2026-02-26 | $250.00M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-03-31 | $148.00M 10-Q · filed 2024-04-24 | $148.00M derived: sum of 2 quarters · filed 2026-02-26 | $150.00M derived: sum of 3 quarters · filed 2026-02-26 | ||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.00M derived: sum of 2 quarters · filed 2026-02-26 | $699.00M 10-K · filed 2026-02-26 | ||
| 2023-09-30 | $2.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-25 | $699.00M 10-Q · filed 2023-10-25 | |||
| 2023-06-30 | $697.00M 10-Q · filed 2023-07-27 | ||||
| 2022-12-31 | $162.00M 10-K · filed 2025-02-20 | ||||
| 2021-12-31 | $346.00M 10-K · filed 2024-02-22 | $336.00M 10-K · filed 2022-02-28 | |||
| 2020-12-31 | $330.00M 10-K · filed 2023-02-21 | ||||
| 2019-12-31 | $63.00M 10-K · filed 2022-02-28 | ||||
| 2018-12-31 | $440.00M 10-K · filed 2021-02-22 | ||||
| 2017-12-31 | $587.00M 10-K · filed 2020-02-20 | ||||
| 2016-12-31 | $139.00M 10-K · filed 2019-02-21 | ||||
| 2015-12-31 | $63.00M 10-K · filed 2018-02-23 | ||||
| 2014-12-31 | $768.00M 10-K · filed 2017-02-22 | ||||
| 2013-12-31 | $264.00M 10-K · filed 2016-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |